U.S. Markets closed

Chinese investors lead another monster round into this early cancer detection company

Ron Leuty
American City Business Journals
Chinese investors lead another monster round into this early cancer detection company

The Menlo Park company had already raised $1.2 billion; now it's adding $300 million, mainly from Chinese investors, as it aims to develop a simple blood test to discover cancers early.